Obesity Clinical Trial
— WW ClinicOfficial title:
24 Week External Single-arm Study Testing the Effectiveness of WW GLP1 Behavioral Program + Sequence Medical Weight Management on Weight Loss and Related Outcomes
Verified date | March 2024 |
Source | The Cleveland Clinic |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The study objective is to evaluate the efficacy of the WeightWatchers (WW) GLP-1 behavioral program + WW Clinic (formerly known as Sequence medical weight management program) on weight loss and related outcomes. Participants will be invited to take part and answer surveys at 0, 12 and 24 weeks.
Status | Enrolling by invitation |
Enrollment | 180 |
Est. completion date | June 1, 2025 |
Est. primary completion date | December 31, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion criteria: 1. 18 years or older 2. BMI of >30 or BMI of >27 with one or more weight related medically qualifying condition (hypertension, dyslipidemia, sleep apnea, cardiovascular disease) 3. Access to a smartphone or tablet that runs iOS/iPadOS 15.0 or later, or Android 7.0 or later 4. A prescription for Wegovy, Mounjaro, or Zepbound Exclusion criteria: 1. Diabetes 2. Personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia type 2 3. History of pancreatitis within 180 days 4. Previous surgical obesity treatment 5. Use of other anti-obesity medication in last 90 days 6. Use of GLP-1 within the last 180 days 7. Lost weight >11 lbs in the last 90 days 8. Pregnant, breastfeeding, intends to become pregnant, of child-bearing potential and not using a highly effective contraceptive method |
Country | Name | City | State |
---|---|---|---|
United States | Cleveland Clinic | Cleveland | Ohio |
Lead Sponsor | Collaborator |
---|---|
The Cleveland Clinic |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Blood pressure changes (systolic and diastolic) in mmHg from week 0 to week 24 | Effect of WW + WW Clinic (formerly known as Sequence) on blood pressure changes at 24 weeks | 0 to 24 weeks | |
Other | Change in Quality of Life scores from week 0 to week 24 | Effect of WW + WW Clinic (formerly known as Sequence) on Quality of Life (QOL) scores | 0 to 24 weeks | |
Other | Changes in Well-being scores from week 0 to week 24 | Effect of WW + WW Clinic (formerly known as Sequence) on Well-being at 24 weeks | 0 to 24 weeks | |
Other | Changes in Physical Activity scores from week 0 to week 24 | Effect of WW + WW Clinic (formerly known as Sequence) on Physical Activity at 24 weeks | 0 to 24 weeks | |
Other | Changes in Diet Quality scores from week 0 to week 24 | Effect of WW + WW Clinic (formerly known as Sequence) on Diet Quality at 24 weeks | 0 to 24 weeks | |
Other | Changes in Hunger scores from week 0 to week 24 | Effect of WW + WW Clinic (formerly known as Sequence)on Hunger scores at 24 weeks | 0 to 24 weeks | |
Other | Changes in Stress scores from week 0 to week 24 | Effect of WW + WW Clinic (formerly known as Sequence) on Stress at 24 weeks | 0 to 24 weeks | |
Other | Changes in Internalized Weight Bias scores from week 0 to week 24 | Effect of WW + WW Clinic (formerly known as Sequence) on Internalized Weight Bias | 0 to 24 weeks | |
Other | Changes in Emotional Eating scores from week 0 to week 24 | Effect of WW + WW Clinic (formerly known as Sequence) on Emotional Eating scores | 0 to 24 weeks | |
Other | Changes in Satisfaction scores from week 0 to week 24 | Effect of WW + WW Clinic (formerly known as Sequence) on Satisfaction scores | 0 to 24 weeks | |
Other | Changes in Community scores from week 0 to week 24 | Effect of WW + WW Clinic (formerly known as Sequence) on Community scores | 0 to 24 weeks | |
Other | Changes in Habit Strength scores from week 0 to week 24 | Effect of WW + WW Clinic (formerly known as Sequence) on Habit Strength scores | 0 to 24 weeks | |
Other | Changes in Food Craving scores from week 0 to week 24 | Effect of WW + WW Clinic (formerly known as Sequence) on Food Craving scores | 0 to 24 weeks | |
Other | Changes in Self-Compassion scores from week 0 to week 24 | Effect of WW + WW Clinic (formerly known as Sequence) on Self-Compassion scores | 0 to 24 weeks | |
Other | Changes in Disordered Eating Behaviors scores from week 0 to week 24 | Effect of WW + WW Clinic (formerly known as Sequence) on Disordered Eating Behavior scores | 0 to 24 weeks | |
Other | Changes in reported GLP1 Side Effects from week 0 to week 24 | Effect of WW + WW Clinic (formerly known as Sequence) on Side Effects scores | 0 to 24 weeks | |
Other | Changes in Restraint/Disinhibition scores from week 0 to week 24 | Effect of WW + WW Clinic (formerly known as Sequence) on Ristraint/Disinhibition scores | 0 to 24 weeks | |
Other | Changes in Body Appreciation scores from week 0 to week 24 | Effect of WW + WW Clinic (formerly known as Sequence) on Body Appreciation scores | 0 to 24 weeks | |
Other | Changes in Depression symptom scores from week 0 to week 24 | Effect of WW + WW Clinic (formerly known as Sequence) on Depression symptoms | 0 to 24 weeks | |
Primary | Change in weight in pounds from week 0 to week 24 | Effect of WW GLP1 behavioral program + WW Clinic (formerly known as Sequence) on weight loss at 24 weeks. | 0 to 24 weeks | |
Secondary | Weight loss percentage change from week 0 to week 24 | Effect of WW + WW Clinic (formerly known as Sequence) on weight loss at 12 weeks and % reaching 5, 10, 15, 20 % body weight loss at 24 weeks. | 0 to 24 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |